Popular topics to explore
KIMS
Krishna Institute Of Medical Sciences Ltd. (KIMS), with a market cap of ₹26,438.19 crore, is one of India's largest healthcare providers, operating a chain of multi-specialty hospitals across multiple states. The company reported revenues of ₹1,343.05 crore and an EPS growth of 11%, reflecting consistent profitability. With a healthy ROE of 18% and cash flow per share of ₹6.56, it demonstrates operational efficiency. An earnings stability score of 65 further highlights the reliability of its financial performance.
Currently trading at a P/E of 33, within its 3-year historical range of 13–30, the stock's valuation appears reasonable relative to its past performance. Recent price action shows a recovery after a period of volatility, and the stock is trading above key moving averages, suggesting a potential bullish trend. Investors might view KIMS as a stable player in the healthcare sector with consistent growth, while monitoring its expansion plans and regulatory environment.#TechnicalViews#FundamentalViews
156 likes·69 comments

















